Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NXTSTIM is a San Diego-based neuromodulation and digital health company developing non-invasive, AI-enabled pain management solutions. Its lead commercial product, EcoAI, is an FDA-cleared wearable neurostimulation device that combines transcutaneous electrical nerve stimulation and electromyographic stimulation with remote therapeutic monitoring and app-based therapy management. The company positions EcoAI as a closed-loop ecosystem for personalized, drug-free chronic pain care, enabling clinicians to monitor patient use and outcomes remotely. NXTSTIM also offers a digital care platform and care coordination services designed to improve adherence, optimize therapy, and fit into clinical reimbursement workflows. The company appears focused on commercialization rather than a traditional drug-development pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NXTSTIM.